Insider Transactions in Q2 2021 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2021
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
916
+50.0%
|
$20,152
$22.95 P/Share
|
|
Apr 30
2021
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
495
+5.83%
|
$10,890
$22.95 P/Share
|
|
Apr 30
2021
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
286
+50.0%
|
$6,292
$22.95 P/Share
|
|
Apr 30
2021
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
497
+50.0%
|
$10,934
$22.95 P/Share
|
|
Apr 08
2021
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
2,304,256
-1.58%
|
-
|
|
Apr 08
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
395,744
-1.58%
|
$12,268,064
$31.25 P/Share
|
|
Apr 07
2021
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
15,361,703
-9.54%
|
-
|
|
Apr 07
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,638,297
-9.54%
|
$81,787,207
$31.25 P/Share
|